Beth A. Arthington‐Skaggs

3.8k citations

32 papers · 3.1k indexed · 1 hit paper · h-index 24

Impact in

Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Applied Microbiology and Biotechnology top 1%

Papers in

Applied Microbiology and Biotechnology 3
- Antibiotic Use and Resistance 3
Infectious Diseases 27
- Antifungal resistance and susceptibility 26

Co-authors: David W. Warnock Christine J. Morrison Arnaldo Lopes Colombo Juliette Morgan Tejal A. Desai Hoda Jradi Rana Hajjeh Wendy Lee‐Yang
Journals: Journal of Clinical Microbiology (10 papers)Antimicrobial Agents and Chemotherapy (9 papers)Medical Mycology (6 papers)Clinical Infectious Diseases (2 papers)Infection Genetics and Evolution (1 paper)
Partner nations: United States Brazil United Kingdom

In The Last Decade

Beth A. Arthington‐Skaggs

32 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program 2004 · 519 citations

Peers

Countries citing papers authored by Beth A. Arthington‐Skaggs

Since Specialization

Citations

This map shows the geographic impact of Beth A. Arthington‐Skaggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth A. Arthington‐Skaggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth A. Arthington‐Skaggs more than expected).

Fields of papers citing papers by Beth A. Arthington‐Skaggs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth A. Arthington‐Skaggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth A. Arthington‐Skaggs. The network helps show where Beth A. Arthington‐Skaggs may publish in the future.

Co-authors

The 25 scholars most cited alongside Beth A. Arthington‐Skaggs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beth A. Arthington‐Skaggs Line = papers co-authored together Beth A. Arthington‐Skaggs links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of serum and surface characteristics on Candida albicans biofilm formation Mycoses ·João P. Frade, Beth A. Arthington‐Skaggs	2010	50
2	Biofilm production and evaluation of antifungal susceptibility amongst clinicalCandidaspp. isolates, including strains of theCandida parapsilosiscomplex Medical Mycology ·Analy Salles de Azevedo Melo, Fernando César Bizerra, Edna Freymüller, Beth A. Arthington‐Skaggs, Arnaldo Lopes Colombo	2010	152
3	Guidelines for the prevention, diagnosis and management of cryptococcal meningitis and disseminated cryptococcosis in HIV-infected patients Southern African Journal of HIV Medicine ·Kerrigan McCarthy, Graeme Meintjes, Beth A. Arthington‐Skaggs, Tihana Bicanic, Mark F. Cotton, Tom Chiller, Nelesh P. Govender, Thomas S. Harrison, Hasan Abdalmonem Agamia, Gary Maartens, S L Kaplan, François Venter, Hester F. Vismer	2007	33
4	Paradoxical Growth Effect of Caspofungin Observed on Biofilms and Planktonic Cells of Five Different Candida Species Antimicrobial Agents and Chemotherapy ·Analy Salles de Azevedo Melo, Arnaldo Lopes Colombo, Beth A. Arthington‐Skaggs	2007	103
5	Molecular epidemiology of Candida parapsilosis sepsis from outbreak investigations in neonatal intensive care units Infection Genetics and Evolution ·A H Maartje, Brent A. Lasker, Naureen Iqbal, Michael J. James, Beth A. Arthington‐Skaggs	2007	26
6	Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome Antimicrobial Agents and Chemotherapy ·Benjamin J. Park, Beth A. Arthington‐Skaggs, Rana Hajjeh, Naureen Iqbal, Meral A. Cıblak, Wendy Lee‐Yang, Nina Krljar, Maureen Phelan, Brian D. Plikaytis, André N. Sofair, Lee H. Harrison, Scott K. Fridkin, David W. Warnock	2006	95
7	Cryptococcus gattiiInfection: Characteristics and Epidemiology of Cases Identified in a South African Province with High HIV Seroprevalence, 2002–2004 Clinical Infectious Diseases ·Juliette Morgan, Kerrigan McCarthy, Susan Martin Gould, A. Gopinath, Beth A. Arthington‐Skaggs, Naureen Iqbal, Karen Stamey, Rana Hajjeh, Mary E. Brandt, (unknown)	2006	61
8	Epidemiology of Community‐Onset Candidemia in Connecticut and Maryland Clinical Infectious Diseases ·André N. Sofair, G. Marshall Lyon, Csaba Grépály, Errol Reiss, Lee H. Harrison, Laurie Thomson Sanza, Beth A. Arthington‐Skaggs, Scott K. Fridkin	2006	42
9	Comparison of multilocus sequence typing and Ca3 fingerprinting for molecular subtyping epidemiologically-related clinical isolates ofCandida albicans Medical Mycology ·Anuradha Chowdhary, Wendy Lee‐Yang, Brent A. Lasker, Mary E. Brandt, David W. Warnock, Beth A. Arthington‐Skaggs	2006	22
10	Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers Journal of Clinical Microbiology ·Arnaldo Lopes Colombo, Márcio Nucci, Benjamin J. Park, Simone Aranha Nouér, Beth A. Arthington‐Skaggs, Daniel Archimedes da Matta, David W. Warnock, Juliette Morgan	2006	401
11	Interlaboratory Study of Quality Control Isolates for a Broth Microdilution Method (Modified CLSI M38-A) for Testing Susceptibilities of Dermatophytes to Antifungals Journal of Clinical Microbiology ·Mahmoud A. Ghannoum, Beth A. Arthington‐Skaggs, Vishnu Chaturvedi, Ana Espinel‐Ingroff, Michael A. Pfaller, Robert Rennie, Michael G. Rinaldi, Thomas J. Walsh	2006	33
12	Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole Antimicrobial Agents and Chemotherapy ·Annemarie Borst, Qiang Hu, David W. Warnock, Christine J. Morrison, Beth A. Arthington‐Skaggs	2005	86
13	In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance Antimicrobial Agents and Chemotherapy ·Márcia Eliana da Silva Ferreira, Xxxx, Everaldo dos Reis Marques, Iran Malavazi, David S. Perlin, Steven Park, James B. Anderson, Arnaldo Lopes Colombo, Beth A. Arthington‐Skaggs, Maria Helena S. Goldman, Gustavo H. Goldman	2004	111
14	Fungemia Caused by Zygoascus hellenicus in an Allogeneic Stem Cell Transplant Recipient Journal of Clinical Microbiology ·Mary E. Brandt, Carol A. Kauffman, Peter G. Pappas, Naureen Iqbal, Beth A. Arthington‐Skaggs, Wendy Lee‐Yang, Maudy Th. Smith	2004	6
15	Candida albicans Sterol C-14 Reductase, Encoded by the ERG24 Gene, as a Potential Antifungal Target Site Antimicrobial Agents and Chemotherapy ·Nan Jia, Beth A. Arthington‐Skaggs, Etm Cheung, C. A. Pierson, N. Douglas Lees, James A. Eckstein, Robert J. Barbuch, Martin Bard	2002	49
16	Comparative Evaluation of PASCO and National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Yeasts Journal of Clinical Microbiology ·Beth A. Arthington‐Skaggs, Shengjiao Zhu, David W. Warnock, Christine J. Morrison	2000	5
17	In vitro antifungal susceptibility methods and clinical implications of antifungal resistance Medical Mycology ·Ewa Pasquereau-Kotula, Gicelda Julia Dal Bó, Abdul Quadir Barbhuiya, Beth A. Arthington‐Skaggs	2000	1
18	Quantitation of Ergosterol Content: Novel Method for Determination of Fluconazole Susceptibility of Candida albicans Journal of Clinical Microbiology ·Beth A. Arthington‐Skaggs, Hoda Jradi, Tejal A. Desai, Christine J. Morrison	1999	307
19	Antifungal drug susceptibility testing and resistance in Aspergillus Drug Resistance Updates ·David W. Warnock, Beth A. Arthington‐Skaggs, Renkai Li	1999	23
20	Positive and negative regulation of a sterol biosynthetic gene (ERG3) in the post‐squalene portion of the yeast ergosterol pathway FEBS Letters ·Beth A. Arthington‐Skaggs, Dring N. Crowell, Hongyuan Yang, Stephen L. Sturley, Martin Bard	1996	65

About Beth A. Arthington‐Skaggs

Beth A. Arthington‐Skaggs is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Clinical Biochemistry, Endocrinology and Epidemiology, having authored 32 papers that have together received 3.1k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (26 papers), Fungal Infections and Studies (12 papers), Nail Diseases and Treatments (7 papers), Bacterial Identification and Susceptibility Testing (5 papers), Infectious Diseases and Mycology (4 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotic Use and Resistance (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Infectious Diseases (2.3k citations), Applied Microbiology and Biotechnology (131 citations), Epidemiology (1.7k citations), Periodontics (113 citations) and Cell Biology (315 citations). Beth A. Arthington‐Skaggs has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include David W. Warnock, Christine J. Morrison, Arnaldo Lopes Colombo, Juliette Morgan, Tejal A. Desai, Hoda Jradi, Rana Hajjeh, Wendy Lee‐Yang, Mary E. Brandt and Meral A. Cıblak. Their work appears in journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy, Medical Mycology, Clinical Infectious Diseases and Infection Genetics and Evolution.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact